Table 1.
Clinical characteristics of study patients
| LN |
OW |
OB |
||||
|---|---|---|---|---|---|---|
| Males (n = 17) | Females (n = 11) | Males (n = 11) | Females (n = 10) | Males (n = 10) | Females (n = 16) | |
| Maternal age, yr | 28.6 ± 1.25 | 28.5 ± 1.6 | 30.2 ± 1.9 | 28.8 ± 0.92 | 28.1 ± 1.0 | 27.5 ± 1.0 |
| Ethnicity (Hispanic/non-Hispanic) | 12/5 | 10/1 | 9/2 | 7/3 | 7/3 | 15/1 |
| Gestational age, wk | 39.1 ± 0.2 | 38.7 ± 0.2 | 38.7 ± 0.3 | 39.0 ± 0.3 | 38.6 ± 0.3 | 38.8 ± 0.3 |
| Prepregnancy BMI, kg/m2 | 22.4 ± 0.4 | 21.9 ± 0.6 | 27.5 ± 0.5* | 27.3 ± 0.4* | 33.4 ± 1.4* | 34.5 ± 0.9* |
| Weight gain, lbs. | 29.0 ± 3.0 | 26.4 ± 3.0 | 24.5 ± 1.8 | 26.8 ± 5.5 | 19.2 ± 4.4 | 13.4 ± 5.4* |
| Placental weight, g | 755 ± 39 | 702 ± 14 | 724 ± 40 | 785 ± 43 | 793 ± 61 | 718 ± 47 |
| Fetal weight, g | 3,388 ± 73 | 3,128 ± 106# | 3,488 ± 136 | 3,268 ± 1,433 | 3,360 ± 99 | 3,409 ± 77* |
Values are means ± SE. LN, lean; OW, overweight; OB, obese. Significant differences were determined using a 1-way ANOVA and Bonferroni post hoc testing for each sex relative to the LN group.
*
P < 0.05 vs. LN group;
#
P < 0.05 vs. males within the same group of adiposity. Sample sizes are given for males and females.